Perpetual Ltd’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$570K Buy
13,344
+7,944
+147% +$431K 0.01% 310
2026
Q1
$339K Sell
5,400
-21
-0.4% -$1.68K 0.01% 374
2025
Q4
$517K Buy
5,421
+1,613
+42% +$158K 0.01% 303
2025
Q3
$372K Buy
3,808
+1,692
+80% +$175K ﹤0.01% 354
2025
Q2
$227K Sell
2,116
-71
-3% -$7.18K ﹤0.01% 402
2025
Q1
$221K Sell
2,187
-72
-3% -$7.25K ﹤0.01% 400
2024
Q4
$202K Sell
2,259
-236
-9% -$20.8K ﹤0.01% 406
2024
Q3
$209K Sell
2,495
-867
-26% -$68.3K ﹤0.01% 409
2024
Q2
$259K Sell
3,362
-471
-12% -$34.5K ﹤0.01% 398
2024
Q1
$263K Sell
3,833
-651
-15% -$41.9K ﹤0.01% 404
2023
Q4
$259K Sell
4,484
-11,560
-72% -$617K ﹤0.01% 403
2023
Q3
$847K Buy
16,044
+7,442
+87% +$390K 0.01% 297
2023
Q2
$465K Sell
8,602
-1,359
-14% -$71K ﹤0.01% 384
2023
Q1
$498K Buy
+9,961
New +$469K ﹤0.01% 397
2020
Q3
$13.4M Sell
350,072
-221,580
-39% -$8.54M 0.96% 18
2020
Q2
$20.1M Buy
571,652
+393,614
+221% +$14.2M 1.88% 11
2020
Q1
$5.81M Buy
+178,038
New +$6.96M 0.82% 31

Other funds holding BSX

Perpetual Ltd's BSX Position: Q2 2026 in Review

Perpetual Ltd increased its Boston Scientific (BSX) stake by 147% in Q2 2026, buying an estimated $431K and bringing the position to 13,344 shares worth $570K. The position accounts for 0.01% of the portfolio, ranked #310.

Perpetual Ltd first reported a position in BSX in Q1 2020 and has held it in 17 quarters since. The position peaked at $20.1M in Q2 2020. 434 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Perpetual Ltd held 13,344 shares of Boston Scientific worth $570K as of Q2 2026.
  • Perpetual Ltd bought 7,944 Boston Scientific shares in Q2 2026, an estimated $431K.
  • Boston Scientific made up 0.01% of Perpetual Ltd's portfolio in Q2 2026, its #310 holding.
  • Perpetual Ltd first reported a position in Boston Scientific in Q1 2020 and has held it in 17 quarters since.
  • Perpetual Ltd's Boston Scientific position peaked at $20.1M in Q2 2020.
  • 434 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.